These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12678489)

  • 1. O-fucose modifications of epidermal growth factor-like repeats and thrombospondin type 1 repeats: unusual modifications in unusual places.
    Shao L; Haltiwanger RS
    Cell Mol Life Sci; 2003 Feb; 60(2):241-50. PubMed ID: 12678489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fringe modifies O-fucose on mouse Notch1 at epidermal growth factor-like repeats within the ligand-binding site and the Abruptex region.
    Shao L; Moloney DJ; Haltiwanger R
    J Biol Chem; 2003 Mar; 278(10):7775-82. PubMed ID: 12486116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two distinct pathways for O-fucosylation of epidermal growth factor-like or thrombospondin type 1 repeats.
    Luo Y; Nita-Lazar A; Haltiwanger RS
    J Biol Chem; 2006 Apr; 281(14):9385-92. PubMed ID: 16464858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian Notch1 is modified with two unusual forms of O-linked glycosylation found on epidermal growth factor-like modules.
    Moloney DJ; Shair LH; Lu FM; Xia J; Locke R; Matta KL; Haltiwanger RS
    J Biol Chem; 2000 Mar; 275(13):9604-11. PubMed ID: 10734111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-alkynyl fucose is a bioorthogonal analog for O-fucosylation of epidermal growth factor-like repeats and thrombospondin type-1 repeats by protein O-fucosyltransferases 1 and 2.
    Al-Shareffi E; Chaubard JL; Leonhard-Melief C; Wang SK; Wong CH; Haltiwanger RS
    Glycobiology; 2013 Feb; 23(2):188-98. PubMed ID: 23045360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of receptor signaling by glycosylation: fringe is an O-fucose-beta1,3-N-acetylglucosaminyltransferase.
    Haltiwanger RS; Stanley P
    Biochim Biophys Acta; 2002 Dec; 1573(3):328-35. PubMed ID: 12417415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lunatic fringe, manic fringe, and radical fringe recognize similar specificity determinants in O-fucosylated epidermal growth factor-like repeats.
    Rampal R; Li AS; Moloney DJ; Georgiou SA; Luther KB; Nita-Lazar A; Haltiwanger RS
    J Biol Chem; 2005 Dec; 280(51):42454-63. PubMed ID: 16221665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fringe is a glycosyltransferase that modifies Notch.
    Moloney DJ; Panin VM; Johnston SH; Chen J; Shao L; Wilson R; Wang Y; Stanley P; Irvine KD; Haltiwanger RS; Vogt TF
    Nature; 2000 Jul; 406(6794):369-75. PubMed ID: 10935626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fringe GlcNAc-transferases differentially extend O-fucose on endogenous NOTCH1 in mouse activated T cells.
    Matsumoto K; Kumar V; Varshney S; Nairn AV; Ito A; Pennarubia F; Moremen KW; Stanley P; Haltiwanger RS
    J Biol Chem; 2022 Jul; 298(7):102064. PubMed ID: 35623385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and transportation pathways of GDP-fucose that are required for the O-fucosylation of Notch.
    Yamakawa T; Ayukawa T; Matsuno K
    Adv Exp Med Biol; 2012; 727():37-46. PubMed ID: 22399337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch ligands are substrates for protein O-fucosyltransferase-1 and Fringe.
    Panin VM; Shao L; Lei L; Moloney DJ; Irvine KD; Haltiwanger RS
    J Biol Chem; 2002 Aug; 277(33):29945-52. PubMed ID: 12036964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch signaling in normal and disease States: possible therapies related to glycosylation.
    Rampal R; Luther KB; Haltiwanger RS
    Curr Mol Med; 2007 Jun; 7(4):427-45. PubMed ID: 17584081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of Properly Folded Epidermal Growth Factor-Like (EGF) Repeats and Glycosyltransferases Enables In Vitro O-Glycosylation.
    Ma C; Tsukamoto Y; Takeuchi H
    Methods Mol Biol; 2022; 2472():27-38. PubMed ID: 35674889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for analysis of O-linked modifications on epidermal growth factor-like and thrombospondin type 1 repeats.
    Nita-Lazar A; Haltiwanger RS
    Methods Enzymol; 2006; 417():93-111. PubMed ID: 17132500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fringe-mediated extension of O-linked fucose in the ligand-binding region of Notch1 increases binding to mammalian Notch ligands.
    Taylor P; Takeuchi H; Sheppard D; Chillakuri C; Lea SM; Haltiwanger RS; Handford PA
    Proc Natl Acad Sci U S A; 2014 May; 111(20):7290-5. PubMed ID: 24803430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the Fringe-Mediated Notch Code: Identification of Activating and Inhibiting Sites Allowing Discrimination between Ligands.
    Kakuda S; Haltiwanger RS
    Dev Cell; 2017 Jan; 40(2):193-201. PubMed ID: 28089369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological functions of glycosyltransferase genes involved in O-fucose glycan synthesis.
    Okajima T; Matsuura A; Matsuda T
    J Biochem; 2008 Jul; 144(1):1-6. PubMed ID: 18272537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of epidermal growth factor-like repeats with O-fucose. Molecular cloning and expression of a novel GDP-fucose protein O-fucosyltransferase.
    Wang Y; Shao L; Shi S; Harris RJ; Spellman MW; Stanley P; Haltiwanger RS
    J Biol Chem; 2001 Oct; 276(43):40338-45. PubMed ID: 11524432
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Takeuchi H; Yu H; Hao H; Takeuchi M; Ito A; Li H; Haltiwanger RS
    J Biol Chem; 2017 Sep; 292(38):15964-15973. PubMed ID: 28729422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of unusual O-glycans in intercellular signaling.
    Luther KB; Haltiwanger RS
    Int J Biochem Cell Biol; 2009 May; 41(5):1011-24. PubMed ID: 18952191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.